Disclosures for "Antiseizure Medication Treatment Patterns, Reasons for Disruption, and Side Effects for Patients with Dravet Syndrome or Lennox-Gastaut Syndrome: A Retrospective Analysis of US Physician Notes "
-
Ms. Lu has received personal compensation for serving as an employee of Takeda Pharmaceuticals USA Inc.. Ms. Lu has stock in Takeda Pharmaceuticals USA, Inc..
-
Mr. Iwanyckyj has received personal compensation for serving as an employee of Amplity Health.
-
The institution of Ms. Wade has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. The institution of Ms. Wade has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for J&J. The institution of Ms. Wade has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Kite Pharma.
-
Mr. Racana has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amplity Health.
-
Mr. Otalora has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amplity Health.
-
Dr. Rao has received personal compensation for serving as an employee of Takeda Pharmaceuticals USA, Inc.. Dr. Rao has stock in Takeda Pharmaceuticals USA, Inc..